Where Pharma Science Meets Commercial Impact
India's integrated pharma consulting and execution partner. Built by pharmaceutical engineers. Trusted by 150+ healthcare organizations.
Trusted by leading pharma & healthcare brands
Meet Pharos, the intelligence layer that turns signals into decisions.
Illuminating critical decisions across pharma, from drug safety to the last mile of the field force.
Pharos Signal shows declining prescriptions in North India. Pharos Deploy recommends reallocating 12 MRs. Pharos RouteIQ optimises field coverage, one connected decision, three modules, in a single platform.
Meet the people behind the process.
Our pharma business is led by Aditi Tripathi and built on a foundation laid by IIT (BHU) + IIM founder-directors.
Aditi Tripathi
Business Lead
Leads the Ichelon pharma consulting business end to end.
Rohit Gupta
Co-Founder & Director, Business
A pharmaceutical engineer (IIT BHU, B.Tech + M.Tech Pharma Engineering) with an IIM Rohtak MBA, Rohit owns business strategy and the lead-to-engagement journey, bringing the commercial lens that connects science to prescription outcomes.
Abhash Kumar
Co-Founder & Director, Strategy
A pharmaceutical engineer (IIT BHU) with an IIM Bangalore MBA, Abhash leads content and scientific strategy and quality governance, setting the standard for scientific rigour across every engagement.
Deep Das
Co-Founder & Director, Operations
A pharmaceutical engineer (IIT BHU, B.Tech + M.Tech Pharma Engineering), Deep oversees production and delivery, guardian of the SOP-governed workflow and the 4-layer QC that underpins the Publication Readiness System™.
A 60+ person in-house team of physicians, pharmacists, medical writers and data scientists stands behind them. Meet the full leadership team
What pharma teams say about working with us.
We were losing months to desk rejections we could not explain. Ichelon rebuilt our pre-submission process around journal fit and embedded reporting standards, and our acceptance rate on first submission climbed noticeably within two cycles.
The literature monitoring used to be a black box at audit. Now every search is reproducible and every decision is traceable. Our last inspection was the calmest one we have had.
For the first time our PV staffing is something I can actually defend with data. Risk-tiered drugs, activity-level plans, no more arguing about headcount on gut feel.
Strong science doesn't guarantee commercial impact. We close that gap.
Evidence that doesn't land
Scientifically robust brands struggle to communicate their evidence compellingly to HCPs and field teams.
Pipelines that stall at the last mile
Publication pipelines stall, not because of poor science, but poor process governance.
Spend that can't be traced
Channel investments rarely connect back to measurable prescription outcomes.
Ichelon bridges the gap between scientific excellence and commercial performance, across publication strategy, brand communication, field force enablement and commercial intelligence. Built by pharmaceutical engineers. Governed by structured methodology. Powered by proprietary technology.
Explore Our ServicesFrom Scientific Publication to Commercial Intelligence, One Strategic Partner.
Scientific Writing & Medical Communications
Submission-ready publications and compelling medical affairs assets.
Explore PracticeBrand Communications & Marketing
Therapy-aware brand campaigns and field force tools, from brief to deployment.
Explore PracticePharma Technology Solutions
Three proprietary tools that eliminate high-friction activities in pharma writing and PV operations.
Explore PracticeChannel Engagement
Structured, trackable engagement programs that connect field investments to prescription outcomes.
Explore PracticeBusiness Intelligence Systems
Predictive insights and end-to-end automation for pharma commercial operations.
Explore PracticeNot sure where to start? Tell us your challenge and we'll recommend the right practice. Start a Conversation
We operate as a controlled process partner, not a content vendor.
Publication Readiness System™
4-layer sequential QC, Scientific, Editorial, Compliance, Technical. 100% SOP-governed delivery with version control and audit trails on every deliverable.
See Our Quality ArchitectureProprietary Technology Advantage
Three in-house tools for high-friction pharma activities: AI-verified journal intelligence, FAERS-based PV resource allocation and audit-ready literature monitoring.
Explore Our ToolsIIT + IIM Pharma Experts
Led by IIT (BHU) pharmaceutical engineers with IIM management expertise. Every engagement is led by professionals who understand the science behind your brand.
Meet Our TeamBuilt for regulated environments, quality, traceability and compliance are requirements, not preferences.
Pharmaceutical Companies
End-to-end publication, brand and commercial support across the product lifecycle.
Clinical Research Organizations (CROs)
FSP and co-sourced scientific writing, PV and literature monitoring capacity.
CDMOs
Regulatory-grade documentation and scientific communication support.
Hospital Research Departments
Manuscript development, systematic reviews and publication strategy.
Principal Investigators
Submission-ready manuscripts with embedded CONSORT/PRISMA/STROBE compliance.
Medical Affairs Teams
KOL decks, MSL materials, product monographs and scientific communication assets.
Pharmacovigilance Departments
PSUR/DSUR writing, FAERS-based resource planning and audit-ready literature monitoring.
Healthcare Institutions
Evidence communication, data visualisation and structured publication programmes.
From the teams who live it.
Why Manuscripts Get Desk-Rejected Before Review (and How to Stop It)
Most desk rejections have nothing to do with the science. They are process failures that are entirely preventable, if you engineer them out before submission.
Read Article Scientific WritingCONSORT and PRISMA Compliance: What Pharma Teams Miss
Reporting guidelines are not a submission checklist. They are a writing architecture, and treating them otherwise is why so many pharma manuscripts stall.
Read Article Pharma TechnologyHow to Choose a Journal Beyond Impact Factor
Impact factor is the worst single metric to select a journal on. Acceptance probability, scope fit and APC reality matter far more.
Read ArticleWe don't just attend the conversation. We convene it.
Ichelon hosts Aarambh, India's first AI Healthcare Summit, and brings pharma, medical, safety and commercial leaders together with the people building applied AI for healthcare. Our directors have spoken and moderated at national stages including the Bihar AI Summit.
How to start working with ICS, it begins with a pilot.
- 1
Share Your Challenge
Tell us about your current project, publication need, brand communication gap or commercial challenge through a 30-minute consultation.
- 2
Receive a Pilot Scope
We define a contained pilot project that lets you evaluate our quality, process governance and turnaround without long-term commitment.
- 3
Experience the ICS Process
We deliver. You evaluate. Our SOP-governed workflow, 4-layer QC and audit trail are visible at every stage.
- 4
Scale the Partnership
Move to a retainer, FSP, co-sourcing or brand-plan partnership, with full confidence in our delivery capability.
Evaluate our quality within one delivery cycle.
No long-term commitments required. Start with a defined pilot project and see exactly how ICS operates before scaling the engagement.